European Commission approves teclistamab plus daratumumab for relapsed/refractory multiple myeloma, offering a... ecancer 16:17 Tue, 25 Aug
Protein degrader approval offers hope to relapsed multiple myeloma patients Chemistry World Magazine 09:29 Tue, 25 Aug
Johnson & Johnson’s multiple myeloma treatment secures EC approval Pharmaceutical Technology 10:06 Mon, 24 Aug
Blenrep clears 1st reimbursement hurdle in Korea for relapsed multiple myeloma Korea Biomedical Review 05:56 Thu, 20 Aug
Hematogenix's Mm Mrd Assay Underpins FDA Accelerated Approval of Bristol Myers Squibb's Zenbexus™, the First Approved CELMoD Therapy for Multiple Myeloma PR Newswire (Press Release) 13:40 Wed, 19 Aug
Zenbexus Granted Accelerated Approval in Relapsed or Refractory Multiple Myeloma Hematology Advisor 15:35 Mon, 17 Aug
Impact of socioeconomic status on treatment and survival in multiple myeloma in Australia Nature.com 01:22 Sat, 15 Aug
Hematogenix's Proprietary MM MRD Assay Underpins FDA Accelerated Approval of Bristol Myers Squibb's ZENBEXUS™, the First Approved CELMoD Therapy for Multiple Myeloma PRWeb (Press Release) 23:30 Fri, 14 Aug
BMS wins FDA accelerated approval for multiple myeloma therapy BioWorld 18:52 Fri, 14 Aug Article paywall
BMS bags first FDA approval for CELMoD franchise with Zenbexus multiple myeloma nod FiercePharma 15:18 Fri, 14 Aug
STAT Plus: FDA approves Bristol multiple myeloma treatment, marking debut of novel drug class STAT 13:07 Fri, 14 Aug
BMS secures FDA accelerated approval for Zenbexus in multiple myeloma Pharmaceutical Business Review 10:44 Fri, 14 Aug
[Interview] ‘Multiple myeloma is nearing the era of cure -- but Korea needs better drugs earlier’ Korea Biomedical Review 06:15 Wed, 12 Aug
Establishment and characterization of multiple myeloma cell lines from a single patient’s disease course immortalizes clonal heterogeneity Nature.com 01:29 Wed, 12 Aug
SFDA becomes first regulatory authority globally to approve registration of 'ZENBEXUS' to treat multiple myeloma in adults Saudi Gazette 22:24 Tue, 11 Aug
High SGK1 Expression Predicts Poor Outcomes After ASCT in Multiple Myeloma Hematology Advisor 15:27 Wed, 05 Aug
FDA clears Ind for Brightpath’s BP-2202 for multiple myeloma BioWorld 15:16 Wed, 05 Aug Article paywall
Balancing Autonomy, Quality of Life, and Long-Term Planning in Multiple Myeloma Medpage Today 16:04 Tue, 04 Aug
Bruce Springsteen Reveals Wife Patti Scialfa Is in Remission After Multiple Myeloma Diagnosis People 09:33 Tue, 04 Aug
Vaxcellbio launches global co-development program for NRC-based NK cell therapy for multiple myeloma Korea Biomedical Review 07:23 Tue, 04 Aug
More options, more questions in the management of early relapsed and/or refractory multiple myeloma Nature.com 11:20 Fri, 31 Jul
Indefinite-Duration Maintenance Therapy No Better Than Fixed-Duration Therapy in Multiple Myeloma Oncology Nurse Advisor 14:09 Thu, 30 Jul
Toward more accurate adverse event attribution in multiple myeloma clinical trials Nature.com 18:11 Tue, 28 Jul
Definition of Functional High-Risk Multiple Myeloma Updated in Era of Combo Therapy Oncology Nurse Advisor 16:02 Mon, 27 Jul
